DSC: Exploring the Safety and Efficacy of Everolimus in PTEN Hamartoma Tumor Syndrome
7 de nov. de 2022 ·
2m 1s
Descarga y escucha en cualquier lugar
Descarga tus episodios favoritos y disfrútalos, ¡dondequiera que estés! Regístrate o inicia sesión ahora para acceder a la escucha sin conexión.
Descripción
New research from the Developmental Synaptopathies Consortium (DSC). This summary is based on a paper published in the journal Human Molecular Genetics on October 15, 2022, titled "A randomized controlled...
mostra más
New research from the Developmental Synaptopathies Consortium (DSC). This summary is based on a paper published in the journal Human Molecular Genetics on October 15, 2022, titled "A randomized controlled trial of everolimus for neurocognitive symptoms in PTEN hamartoma tumor syndrome."
Read the paper here: https://academic.oup.com/hmg/article/31/20/3393/6589680
Learn more about DSC: https://www1.rarediseasesnetwork.org/cms/dsc
mostra menos
Read the paper here: https://academic.oup.com/hmg/article/31/20/3393/6589680
Learn more about DSC: https://www1.rarediseasesnetwork.org/cms/dsc
Información
| Autor | RDCRN |
| Organización | RDCRN |
| Página web | - |
| Etiquetas |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company
Comentarios